孙自敏. 脐血移植临床应用30年的回顾及展望[J]. 器官移植, 2020, 11(2): 199-203. DOI: 10.3969/j.issn.1674-7445.2020.02.004
引用本文: 孙自敏. 脐血移植临床应用30年的回顾及展望[J]. 器官移植, 2020, 11(2): 199-203. DOI: 10.3969/j.issn.1674-7445.2020.02.004
Sun Zimin. Review and prospect of clinical application of umbilical cord blood transplantation for 30 years[J]. ORGAN TRANSPLANTATION, 2020, 11(2): 199-203. DOI: 10.3969/j.issn.1674-7445.2020.02.004
Citation: Sun Zimin. Review and prospect of clinical application of umbilical cord blood transplantation for 30 years[J]. ORGAN TRANSPLANTATION, 2020, 11(2): 199-203. DOI: 10.3969/j.issn.1674-7445.2020.02.004

脐血移植临床应用30年的回顾及展望

Review and prospect of clinical application of umbilical cord blood transplantation for 30 years

  • 摘要: 造血干细胞移植是治愈血液系统恶性肿瘤、造血衰竭性疾病和先天性遗传性代谢性疾病的重要方法。脐血是造血干细胞的主要来源之一,是干细胞研究及应用最理想的细胞来源。本文从脐血移植的历史及现状、脐血移植的优势、脐血移植技术的改进、脐血移植的应用前景及展望等方面,对脐血移植30多年的临床应用进行回顾和展望。

     

    Abstract: Hematopoietic stem cell transplantation is a pivotal method to treat hematological malignancies, hematopoietic failure diseases and inherited metabolic diseases. Umbilical cord blood is one of the main sources of hematopoietic stem cells and the most ideal cell source for stem cell research and application. In this article, the clinical application of umbilical cord blood transplantation for more than 30 years was reviewed from the aspects of the history, current situation, advantages, improvement, application prospect and expectation of umbilical cord blood transplantation.

     

/

返回文章
返回